Risk factors for intensive care unit coronavirus disease 2019 pneumonia-associated invasive fungal infections: a Bayesian evidence synthesis integrating external and real-world data

BACKGROUND: The incidence of Coronavirus Disease 2019 (COVID-19) pneumonia-associated Invasive Fungal Infections (IFI) has risen markedly. However, current evidence regarding associated risk factors remains inconsistent across studies and limited by small sample sizes, underscoring the need for systematically integrated evidence. METHODS: This retrospective study integrated published external evidence with Real-World Data (RWD) within a Bayesian framework to derive more accurate and robust estimates of potential risk factors for IFI associated with COVID-19 pneumonia in Intensive Care Unit (ICU) patients. RESULTS: Based on the study-derived prior distributions for 25 potential risk factors, the Bayesian integrated analysis further suggested that male sex, advanced age, diabetes mellitus, chronic pulmonary disease, hepatic or renal dysfunction, malignancy, increased disease severity (Sequential Organ Failure Assessment (SOFA) scores, Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, and Charlson Comorbidity Index (CCI)), and prolonged mechanical ventilation were possible associated with IFI in ICU patients with COVID-19 pneumonia. In addition, prior glucocorticoid exposure, high-dose and prolonged glucocorticoid therapy, vasopressor use, renal replacement therapy, and mechanical ventilation were also potentially linked to higher IFI incidence. Subgroup analyses revealed that factors associated with Aspergillus infection in COVID-19 patients were largely consistent with the overall cohort. CONCLUSION: This observational study systematically explored potential factors associated with IFI in ICU patients with COVID-19 pneumonia by integrating published external evidence with RWD within a Bayesian framework, thereby providing more reliable evidence to support early identification and prevention in high-risk individuals.

Authors

Institutions

Publication Details

Journal
Virology Journal
Published
2026-04-28
DOI
https://doi.org/10.1186/s12985-026-03183-5
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk factors for intensive care unit coronavirus disease 2019 pneumonia-associated invasive fungal infections: a Bayesian evidence synthesis integrating external and real-world data

Chengyu Wang, Huangxin Gong, Jiatian Wang, Ting Yang et al.
Virology Journal
Antifungal resistance and susceptibility
article

Risk factors for intensive care unit coronavirus disease 2019 pneumonia-associated invasive fungal infections: a Bayesian evidence synthesis integrating external and real-world data

Chengyu Wang, Huangxin Gong, Jiatian Wang, Ting Yang, Yan Wang, Yan Cai, Yuan Wu
article en

Abstract

BACKGROUND: The incidence of Coronavirus Disease 2019 (COVID-19) pneumonia-associated Invasive Fungal Infections (IFI) has risen markedly. However, current evidence regarding associated risk factors remains inconsistent across studies and limited by small sample sizes, underscoring the need for systematically integrated evidence. METHODS: This retrospective study integrated published external evidence with Real-World Data (RWD) within a Bayesian framework to derive more accurate and robust estimates of potential risk factors for IFI associated with COVID-19 pneumonia in Intensive Care Unit (ICU) patients. RESULTS: Based on the study-derived prior distributions for 25 potential risk factors, the Bayesian integrated analysis further suggested that male sex, advanced age, diabetes mellitus, chronic pulmonary disease, hepatic or renal dysfunction, malignancy, increased disease severity (Sequential Organ Failure Assessment (SOFA) scores, Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, and Charlson Comorbidity Index (CCI)), and prolonged mechanical ventilation were possible associated with IFI in ICU patients with COVID-19 pneumonia. In addition, prior glucocorticoid exposure, high-dose and prolonged glucocorticoid therapy, vasopressor use, renal replacement therapy, and mechanical ventilation were also potentially linked to higher IFI incidence. Subgroup analyses revealed that factors associated with Aspergillus infection in COVID-19 patients were largely consistent with the overall cohort. CONCLUSION: This observational study systematically explored potential factors associated with IFI in ICU patients with COVID-19 pneumonia by integrating published external evidence with RWD within a Bayesian framework, thereby providing more reliable evidence to support early identification and prevention in high-risk individuals.

Virology Journal
Second Affiliated Hospital of Xi'an Jiaotong University (CN)
National Natural Science Foundation of China, Wu Jieping Medical Foundation
Openalex Percentile: Top 6%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.